THE ANTI-BCMA ANTIBODY-DRUG CONJUGATE GSK2857916 DRIVES...

HemaSphere 2019 / 06 Vol. 3

THE ANTI-BCMA ANTIBODY-DRUG CONJUGATE GSK2857916 DRIVES IMMUNOGENIC CELL DEATH AND IMMUNE-MEDIATED ANTI-TUMOR RESPONSES, AND IN COMBINATION WITH AN OX40 AGONIST POTENTIATES IN VIVO ACTIVITY

De Oca, Montes R., Bhattacharya, S., Vitali, N., Patel, K., Kaczynski, H., Shi, H. Z., Blackwell, C., Seestaller-Wehr, L., Cooper, D., Jackson, H., Tsvetkov, L., Kepp, O., Creighton-Gutteridge, M., Ho
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000560524.63281.bc
Date:
June, 2019
File:
PDF, 335 KB
2019
Conversion to is in progress
Conversion to is failed